call transcript and quidel corp. Resources | BNET
On The Insider: Hillary to Join Obama

BNET Industries

Quidel Corp. (QDEL) is in the Pharma Industry

Latest News and Analysis

Additional Resources

  • Quidel Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of point-of-care rapid diagnostic tests, announced today that John D. Tamerius, Ph.D., currently vice president, clinical/regulatory affairs, has been promoted to senior vice president, clinical/regulatory affairs, effective November 10, 2008. "It is a pleasure to recognize John's expertise...

    Articles 2008-11-07

  • Quidel Reports Third Quarter 2008 Results

    Earnings Per Share Increased 114 Percent on a 16 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the quarter ended September 30, 2008. Third Quarter & Year-to-Date 2008 Highlights: *...

    Articles 2008-10-22

  • Quidel Corporation Secures New $120 Million Credit Facility

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, today announced that it entered into a new $120 million, five-year senior secured revolving credit facility with a group of four banks. Banc of America Securities, LLC was the sole arranger of the credit facility....

    Articles 2008-10-09

  • Quidel to Hold 2008 Third Quarter Conference Call on October 22, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 third quarter financial results after market close on Wednesday, October 22, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M. Radak,...

    Articles 2008-10-08

  • Quidel Influenza Test Selected for FluSTAR® Surveillance Program

    QuickVue([R]) Test to Be Exclusive for 2008/09 Influenza Season SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, announced today that the QuickVue brand Influenza A+B test is the rapid flu test selected by Roche for use in over 400 physician offices...

    Articles 2008-09-22

  • Quidel to Present at the UBS 2008 Global Life Sciences Conference

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, today announced that it will present at the UBS 2008 Global Life Sciences Conference to be held at the Grand Hyatt Hotel in New York on September 22-25, 2008. Caren Mason, President and...

    Articles 2008-09-16

  • Quidel Reports Second Quarter 2008 Results

    Year-to-Date Net Income Increased 159% on a 20% Increase in Revenues SAN DIEGO -- Conference call information, first U.S. dial-in number should read: 1-800-561-2601 (sted (888) 561-2601). The corrected release reads: QUIDEL REPORTS SECOND QUARTER 2008 RESULTS Year-to-Date Net Income Increased 159%...

    Articles 2008-07-23

  • Quidel to Hold 2008 Second Quarter Conference Call on July 23, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 second quarter financial results after market close on Wednesday, July 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M. Radak,...

    Articles 2008-07-09

  • Quidel and Prodesse Announce Flu and RSV Molecular Partnership

    SAN DIEGO -- Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care POC diagnostic tests, and Prodesse, Inc., a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious diseases, announced today an agreement between the two companies to jointly promote Prodesse's ProFlu+[TM] multiplex molecular diagnostic test...

    Articles 2008-05-20

  • Rapid aid in diagnosis

    The QuickVue Respratory syncytial virus RSV test has been granted CLIA-waived status. This dipstick immunoassay allows for the rapid, qualitative detection of RSV antigen directly from nasopharyngeal swab or nasopharyngeal aspirate specimens for symptomatic pediatric patients (18 and younger). [ILLUSTRATION OMITTED] Quidel Visit www.rsleads.com/805ml-157...

    Articles 2008-05-01

  • Quidel Reports First Quarter 2008 Results

    Earnings Per Share Increased 86 Percent to $0.26 on a 20 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the three months ended March 31, 2008. Recent Highlights: *...

    Articles 2008-04-23

  • Quidel to Hold 2008 First Quarter Conference Call on April 23, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2008 first quarter financial results after market close on Wednesday, April 23, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and John M....

    Articles 2008-04-09

  • Quidel Corporation and Susie's Cause Partner in Colorectal Cancer Awareness Event

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that it is participating at an educational program and special event at "Gunther von Hagens' Body Worlds 2 & The Brain - Our Three Pound Gem" exhibit at the Maryland Science Center in...

    Articles 2008-03-04

  • Urgent news alert: Arthritic Pain Relief, Diabetes Awareness, Point of Care Diagnostic Test FDA Approval of CLIA Waiver & Pharmaceutical Conference Dates Stock News for You.

    M2 PRESSWIRE-29 February 2008-Businessnetwire.us: Urgent news alert: Arthritic Pain Relief, Diabetes Awareness, Point of Care Diagnostic Test FDA Approval of CLIA Waiver & Pharmaceutical Conference Dates Stock News for YouC1994-2008 M2 COMMUNICATIONS LTD RDATE:29022008 New York, NY -- HealthSonix,...

    Articles 2008-02-29

  • Quidel Reports Fourth Quarter and Full Year 2007 Results

    For the Year, Operating Income Increased 41 Percent on an 11 Percent Increase in Revenues SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leader in point-of-care rapid diagnostic tests, today announced financial results for the three months and year ended December 31, 2007. Full Year 2007...

    Articles 2008-02-21

  • BellwetherReport.com Analyst Review for QDEL, BPHX, SHOO and KALU

    BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch on NYSE, NASDAQ, AMEX, TSX, TSX-Venture and US Small-Cap listedcompanies. Investors seeking unbiased research on the companies mentionedare highly encouraged to sign up to www.bellwetherreport.com for a free 90day subscription. Today we have set up...

    Articles 2008-02-19

  • Quidel to Hold 2007 Fourth Quarter and Year-End Financial Results Conference Call on February 21, 2008

    SAN DIEGO -- Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care POC diagnostic tests, will release 2007 fourth quarter and year-end financial results after market close on Thursday, February 21, 2008. Following the release of the results, Caren L. Mason, president and chief executive officer, and...

    Articles 2008-02-11

  • Quidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics

    SAN DIEGO & MARCY L'ETOILE, France -- Quidel Corporation (NASDAQ: QDEL) and bioMerieux (Euronext: BIM) have agreed to form a long-term global alliance in the area of rapid clinical diagnostics for the point-of-care. bioMerieux will become Quidel's primary distributor for its QuickVue([R]) rapid diagnostic tests outside the United States and...

    Articles 2008-01-15

  • Director index

    Ackerman, F. Duane, Home Depot Inc. Adkins, Rodney, Pitney Bowes Inc. Bailey, Robert L., Micron Technology Inc. Bartz, Carol, Intel Corp. Beck, Julie A., Hilb Rogal & Hobbs Co. Beinecke, Candace K., Vornado Realty Trust Benson, Craig, Sycamore...

    Articles 2008-01-01

  • page 1 of 1
advertisement
Quidel Corp. Company Info

Contact Information

10165 McKellar Court

San Diego, CA

http://www.quidel.com

858 552-1100

NAICS Code

In-Vitro Diagnostic Substance Manufacturing: 325413
advertisement